How a specific RNA variant affects inflammation and immune response
Regulation of the Inflammasome by Gasdermin D mRNA Chimerism
This study is looking at a special type of RNA that might help control inflammation and immune responses, which could be important for people dealing with diseases caused by too much inflammation.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard Medical School NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11068769 on NIH RePORTER |
What this research studies
This research investigates the role of a unique RNA variant formed by the fusion of two genes in regulating inflammation and immune responses. By studying how this chimeric mRNA influences the activation of the inflammasome, the research aims to understand its impact on the release of inflammatory signals and cell death. The approach involves using RNA interference techniques to selectively reduce the expression of this RNA variant in immune cells, allowing researchers to observe changes in inflammatory responses. This could lead to insights into how excessive inflammation contributes to various diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from autoinflammatory diseases or conditions associated with excessive inflammation.
Not a fit: Patients with non-inflammatory conditions or those not affected by autoinflammatory diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for managing autoinflammatory diseases and improving immune responses.
How similar studies have performed: Previous research has shown promising results in understanding RNA processing and its implications for immune responses, suggesting that this approach could yield valuable insights.
Where this research is happening
Boston, United States
- Harvard Medical School — Boston, United States (Active)
Researchers
- Principal investigator: Venezia, Olivia L. — Harvard Medical School
- Study coordinator: Venezia, Olivia L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.